Home/Filings/4/0001179110-18-014176
4//SEC Filing

Toselli Richard M. 4

Accession 0001179110-18-014176

CIK 0001292519other

Filed

Dec 19, 7:00 PM ET

Accepted

Dec 20, 3:03 PM ET

Size

6.8 KB

Accession

0001179110-18-014176

Insider Transaction Report

Form 4
Period: 2018-12-18
Toselli Richard M.
Chief Medical Officer
Transactions
  • Tax Payment

    Common Stock

    2018-12-18$1.69/sh961$1,62411,039 total
  • Award

    Common Stock

    2018-12-18+12,00012,000 total
Footnotes (2)
  • [F1]3,000 shares representing the one-for-one conversion of restricted stock units ("RSUs") vested on December 18, 2018. Subject to Dr. Toselli's continued employment with the Company, the remaining 9,000 shares will vest in equal monthly installments until fully vested on December 18, 2021.
  • [F2]Represents shares sold by the reporting person pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2018 to satisfy tax withholding obligations applicable to the vesting of 3,000 stock-settled RSUs referenced in Footnote 1.

Issuer

INVIVO THERAPEUTICS HOLDINGS CORP.

CIK 0001292519

Entity typeother

Related Parties

1
  • filerCIK 0001710549

Filing Metadata

Form type
4
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 3:03 PM ET
Size
6.8 KB